E-LIB Suche - Ergebnisse für: Grimm, Marc-Oliver

1

Healthcare resource utilization and associated costs in pat..:

Niegisch, Günter ; Grimm, Marc-Oliver ; Hardtstock, Fraence...
Journal of Medical Economics. 27 (2024) 1 - p. 531-542 , 2024

Link: https://doi.org/10.1080/..

2

Treatment patterns and clinical outcomes in metastatic urot..:

Niegisch, Günter ; Grimm, Marc-Oliver ; Hardtstock, Fraence...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

3

Corrigendum to "Disease-free Survival Analysis for Patients..:

Galsky, Matthew D. ; Bajorin, Dean F. ; Witjes, Johannes Alfred...
European Urology. 85 (2024) 3 - p. e96-e97 , 2024

Link: https://doi.org/10.1016/..

4

PAE planning: Radiation exposure and image quality of CT an..:

Steiniger, Beatrice ; Fiebich, Martin ; Grimm, Marc-Oliver...
European Journal of Radiology. 172 (2024) - p. 111329 , 2024

Link: https://doi.org/10.1016/..

5

Impact of Prior Cytoreductive Nephrectomy on Efficacy in Pa..:

Grimm, Marc-Oliver ; Oya, Mototsugu ; Choueiri, Toni K....
European Urology. 85 (2024) 1 - p. 8-12 , 2024

Link: https://doi.org/10.1016/..

6

Quality of Life in Patients with High-grade Non–muscle-inva..:

van Straten, Christine G.J.I. ; Caris, Christien ; Grimm, Marc-Oliver...
European Urology Open Science. 56 (2023) - p. 15-24 , 2023

Link: https://doi.org/10.1016/..

7

The Antithetic Roles of IQGAP2 and IQGAP3 in Cancers:

Song, Fei ; Dai, Qingqing ; Grimm, Marc-Oliver.
Cancers. 15 (2023) 4 - p. 1115 , 2023

Link: https://doi.org/10.3390/..

8

67Ga-PSMA I&T for Radioguided Surgery of Lymph Node Metasta..:

Winkens, Thomas ; Berger, Frank Peter ; Foller, Susan...
Clinical Nuclear Medicine. 48 (2023) 7 - p. 600-607 , 2023

Link: https://doi.org/10.1097/..

9

Tailored immunotherapy approach with nivolumab with or with..:

Grimm, Marc-Oliver ; Esteban, Emilio ; Barthélémy, Philippe...
The Lancet Oncology. 24 (2023) 11 - p. 1252-1265 , 2023

Link: https://doi.org/10.1016/..

10

A paired-kidney allocation study found superior survival wi..:

de Fijter, Johan ; Dreyer, Geertje ; Mallat, Marko...
Kidney International. 104 (2023) 3 - p. 552-561 , 2023

Link: https://doi.org/10.1016/..

11

Disease-free Survival Analysis for Patients with High-risk ..:

Galsky, Matthew D. ; Bajorin, Dean F. ; Witjes, Johannes Alfred...
European Urology. 83 (2023) 5 - p. 432-440 , 2023

Link: https://doi.org/10.1016/..

12

A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab..:

McKay, Rana R ; Leucht, Katharina ; Xie, Wanling...
The Oncologist. 29 (2023) 4 - p. 324-331 , 2023

Link: https://doi.org/10.1093/..

13

Discriminative capacity of guideline recommendations in the..:

Kuckuck, Eva Charlotte ; Hennenlotter, Jörg ; Todenhöfer, Tilman...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 5 - p. 254.e1-254.e8 , 2023

Link: https://doi.org/10.1016/..

14

Optimal length and temporal resolution of dynamic contrast-..:

Hellstern, Marius ; Martinez, Carlos ; Wallenhorst, Christopher...
PLOS ONE. 18 (2023) 6 - p. e0287651 , 2023

Link: https://doi.org/10.1371/..

15

Real-World Data on the Use of Nivolumab Monotherapy in the ..:

Grimm, Marc-Oliver ; Grünwald, Viktor ; Müller-Huesmann, Harald...
European Urology Focus. 8 (2022) 5 - p. 1289-1299 , 2022

Link: https://doi.org/10.1016/..